Skip to main content
OpenTrials
Completed

NCT Number: NCT05541055

Digital CBT-I for Insomnia Disorder

This study will examine the effectiveness of digital CBT-I versus sleep hygiene education in reducing insomnia severity, sleep onset latency, and wake after sleep onset in those with insomnia disorder.

Completed

Looking for future studies?

Notify Me

Key information

Age range

22 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of California, San Francisco

San Francisco, California, 94143, United States

About this study

This study aims to examine the effectiveness of a fully-automated web and app-based digital CBT-I for insomnia compared to sleep hygiene education (SHE) in individuals with a diagnosis of insomnia disorder. Primary outcomes of interest include changes in insomnia severity, sleep onset latency, and wake after sleep onset throughout the course of the study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥22 years old
  • Insomnia Disorder diagnosis
  • Score ≤16 on the 8-item Sleep Condition Indicator
  • > 30 minutes sleep onset latency (SOL); and/or > 30 minutes wake after sleep onset (WASO)
  • Current resident of the USA
  • Oral and written fluency in English
  • Participant is able and willing to comply with protocol requirements, has been informed of the nature of the study, and has signed the IRB-approved informed consent form

Exclusion criteria

  • Must not be currently receiving or be expecting to start CBT for insomnia during study participation, or have previously received CBT for insomnia in the past 12-months (self-report)
  • If on psychoactive medication, including sleep medication, this must be stable for at least 5 half lives
  • Past or present psychosis, schizophrenia, bipolar disorder, assessed by self-report and/or seizure disorder
  • Occupation that requires alertness / caution to avoid accidents, for example long-haul driving, long distance bus driver, heavy machinery operator, air traffic controller
  • Hearing or vision impairment that prevents effective use of the audio-visual content of digital CBT-I or SHE in the opinion of the investigator
  • Intellectual disability or any Neurocognitive or Neurodevelopmental disorder that would prevent participants from following study procedures
  • Any condition that the investigator believes would make participation in the study not in the best interest of the participant or would preclude successful completion of study activities

Treatment and study plan

Digital CBT-I

Device

A fully-automated and personalized digital intervention based on principles from cognitive behavioral therapy for insomnia.

Other names: Sleepio

Sleep hygiene education

Other

Participants will be provided with sleep hygiene advice which will be delivered digitally all at once upon allocation to the SHE arm. Participants will be able to revisit content during the trial as they wish.

Primary outcomes

  1. Change in the Insomnia Severity Index (ISI)

    Time frame: From baseline to 10 weeks post-randomization

    Validated questionnaire; a 7-item scale with total scores between 0 and 28 where higher scores indicate greater severity

  2. Change in sleep onset latency (SOL)

    Time frame: From baseline to 10 weeks post-randomization

    Measured by daily sleep diaries (based on the Consensus Sleep Diary) averaged across 10 days

  3. Change in wake after sleep onset (WASO)

    Time frame: From baseline to 10 weeks post-randomization

    Measured by daily sleep diaries (based on the Consensus Sleep Diary) averaged across 10 days

Secondary outcomes

  1. Insomnia Disorder remission (score <8) and response (change ≥6) on the ISI

    Time frame: 10, 16, and 24 weeks post-randomization

    Validated questionnaire; a 7-item scale with total scores between 0 and 28 where higher scores indicate greater severity

  2. Insomnia disorder remission based on the SCID Insomnia Module

    Time frame: Week -1 compared to weeks 10, 16, and 24 post-randomization

    structured interview to assess for Insomnia Disorder

  3. Change in sleep diary parameters: percent sleep efficiency (SE), total sleep time (TST), total time in bed (TTIB), and total wake time (TWT)

    Time frame: From lead-in period to 10, 16, and 24 weeks post-randomization

    Each measured in minutes by daily sleep diaries (based on the Consensus Sleep Diary)

  4. Change in the Sleep Condition Indicator (SCI-8)

    Time frame: From baseline to weeks 10, 16, and 24 post-randomization

    Validated questionnaire; an 8-item scale with total scores between 0 and 32 where higher scores indicate better sleep

  5. Change in the Generalized Anxiety Disorder Questionnaire (GAD-7)

    Time frame: From baseline to weeks 10, 16, and 24 post-randomization

    Validated questionnaire; a 7-item scale with total scores between 0 and 21 where higher scores indicate greater severity

  6. Change in the Patient Health Questionnaire (PHQ-8)

    Time frame: From baseline to weeks 10, 16 and 24 post-randomization

    Validated questionnaire; an 8-item scale with total scores between 0 and 24 where higher scores indicate greater severity

  7. Change in the Insomnia Severity Index (ISI)

    Time frame: From baseline to weeks 16 and 24 post-randomization

    Validated questionnaire; a 7-item scale with total scores between 0 and 28 where higher scores indicate greater severity

  8. Change in sleep onset latency (SOL)

    Time frame: From baseline to weeks 16 and 24 post-randomization

    Measured by daily sleep diaries (based on the Consensus Sleep Diary) averaged across 10 days

  9. Change in wake after sleep onset (WASO)

    Time frame: From baseline to weeks 16 and 24 post-randomization

    Measured by daily sleep diaries (based on the Consensus Sleep Diary) averaged across 10 days

Sponsors and collaborators

Lead sponsor

Big Health Inc.

Industry

Collaborators

  • University of California, San Francisco

Registry information

Official study title

Clinical Effectiveness of Digital CBT-I for the Treatment of Insomnia Disorder: A Randomized Controlled Trial

Acronym: CrEDIT

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Sep 15, 2022
Registry last updated
Apr 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.